Clinical Trials on Type II Gaucher Disease in New Zealand
Total 9478 results
-
KemPharm Denmark A/STerminatedGaucher Disease, Type 1 | Gaucher Disease, Type 3India
-
SanofiRecruitingGaucher's Disease Type IIIUnited States, Germany, Hungary, France, China, Japan, Canada, Argentina, Italy, Turkey
-
Verve Therapeutics, Inc.Not yet recruitingHypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial HypercholesterolemiaNew Zealand, United Kingdom
-
Verve Therapeutics, Inc.Active, not recruitingHypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial HypercholesterolemiaNew Zealand, United Kingdom
-
Amicus TherapeuticsCompletedGaucher Disease | Gaucher Disease, Type 1 | Type 1 Gaucher DiseaseUnited States
-
Genzyme, a Sanofi CompanyActive, not recruitingGaucher Disease Type 1 | Gaucher Disease Type 3Germany, United States, Japan, United Kingdom
-
Arrowhead PharmaceuticalsCompletedDyslipidemias | Hypertriglyceridemia | Familial HypercholesterolemiaAustralia, New Zealand
-
Freeline TherapeuticsRecruitingGaucher Disease, Type 1Spain, Israel, United States, United Kingdom, Brazil, Germany, Paraguay
-
Diatranz Otsuka LimitedCompleted
-
Insulet CorporationCompleted
-
Edgar National Centre for Diabetes ResearchUniversity of OtagoUnknown
-
North Shore Hospital, New ZealandCompletedObesity | Type 2 Diabetes MellitusNew Zealand
-
University of OtagoEdgar National Centre for Diabetes ResearchCompletedObesity | Type 2 Diabetes MellitusNew Zealand
-
Suzhou Alphamab Co., Ltd.Novotech (Australia) Pty LimitedCompleted
-
Genzyme, a Sanofi CompanyWithdrawnGaucher Disease, Type 1United States, India
-
Exsar CorporationSuspendedType I Gaucher DiseaseUnited States
-
Christchurch Clinical Studies Trust LtdMedtronicUnknownType1diabetesNew Zealand
-
Ari ZimranPfizerActive, not recruitingGaucher Disease, Type 3Israel, Turkey, India
-
Tandem Diabetes Care, Inc.Recruiting
-
Provectus PharmaceuticalsCompleted
-
AVROBIOTerminatedType 1 Gaucher DiseaseUnited States, Canada
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsRecruitingGaucher Disease Type 1United States
-
Genzyme, a Sanofi CompanyCompletedGaucher Disease, Type 1 | Cerebroside Lipidosis Syndrome | Glucocerebrosidase Deficiency Disease | Glucosylceramide Beta-Glucosidase Deficiency Disease | Gaucher Disease, Non-Neuronopathic FormUnited States, United Kingdom, Spain, Italy, Brazil, Canada, Poland
-
Auckland District Health BoardNovartis; University of Auckland, New Zealand; IGENZ, Ltd., AucklandUnknownClear Cell Renal Cell CarcinomaNew Zealand
-
AVROBIOTerminatedGaucher DiseaseUnited States, Canada
-
Genzyme, a Sanofi CompanyCompletedGaucher Disease, Type 1United States, United Kingdom, Bulgaria, Canada, Colombia, India, Israel, Lebanon, Mexico, Russian Federation, Serbia, Tunisia
-
PfizerCompletedDiabetes Mellitus, Type IIUnited States
-
ShireApproved for marketingGaucher Disease, Type 1United States
-
ABK BiomedicalCompletedMetastatic Colorectal Cancer | Liver Cancer | Hepatocellular Carcinoma Non-resectableNew Zealand
-
Zhejiang Doer Biologics Co., Ltd.RecruitingHealthy, Obesity, MetabolicallyNew Zealand
-
Genzyme, a Sanofi CompanyCompletedGaucher Disease, Type 1 | Cerebroside Lipidosis Syndrome | Glucocerebrosidase Deficiency Disease | Glucosylceramide Beta-Glucosidase Deficiency Disease | Gaucher Disease, Non-Neuronopathic FormUnited States, Israel, Mexico, Russian Federation, Argentina, Italy
-
Waikato HospitalWellington HospitalRecruitingGlioblastomaNew Zealand
-
Assembly BiosciencesNot yet recruitingRecurrent Genital Herpes Simplex Type 2New Zealand
-
Christchurch HospitalUnknownDiabetes Mellitus, Type 2New Zealand
-
ShireCompletedGaucher Disease, Type 1United States, Israel, Argentina, India, Korea, Republic of, Paraguay, Poland, Russian Federation, Spain, Tunisia, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedGaucher Disease, Type 1United States, France, Germany, Italy, Brazil, Australia, Argentina, Canada, Egypt, Russian Federation, Spain, United Kingdom
-
ShireCompletedGaucher DiseaseUnited States, Spain, United Kingdom, Israel
-
REGENXBIO Inc.Active, not recruitingMucopolysaccharidosis Type II (MPS II)United States, Brazil
-
ShireCompletedGaucher Disease, Type 1Spain, Israel, United States, India, Paraguay, United Kingdom, Russian Federation, Tunisia, Argentina
-
Malaghan Institute of Medical ResearchWellington Zhaotai Therapies Limited (WZTL)RecruitingMantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Lymphomas Non-Hodgkin's B-Cell | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL)New Zealand
-
University of Auckland, New ZealandNorth Shore Hospital, New Zealand; Waikato Hospital; Gut Cancer Foundation, New...Not yet recruitingIntraductal Papillary Mucinous Neoplasm of PancreasNew Zealand
-
ShireCompletedGaucher DiseaseUnited States, Israel, United Kingdom, Poland, Spain
-
Global Preventive Medicine Biotech Co., Ltd.Completed
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Pompe Disease (Late-Onset) | Glycogenesis Type II | Acid Maltase Deficiency (AMD)United States, France, Canada, Netherlands, Australia
-
ActelionCompletedGaucher Disease Type 1United States, Taiwan, Canada, Spain, Australia, France, Brazil, Hungary, Czechia, Germany, Italy, Netherlands, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedPompe Disease | Glycogen Storage Disease Type II (GSD II)United States, Russian Federation, United Kingdom, Bulgaria, India, Ukraine
-
DyaMX Inc.Active, not recruiting
-
Ferzli, George S., M.D. F.A.C.S.UnknownType II DiabetesUnited States
-
American Scitech InternationalProactive Clinical ResearchUnknownType II Diabetes MellitusUnited States, India
-
Future University in EgyptCompleted